Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

CF gene therapy product enters phase II

Feb. 5, 1997

PDE IV/TNF production inhibitors claimed by Pfizer

Feb. 5, 1997

Positive results reported from TOBI pivotal trials

Feb. 4, 1997

Marnac licenses broad-spectrum antifibrotic drug

Feb. 4, 1997

Piperidine derivatives reported by Schering-Plough

Feb. 4, 1997

Sepracor granted U.S. patent for Claritin metabolite

Jan. 31, 1997

Zyflo now available in U.S.

Jan. 30, 1997

New use claimed for maprotiline

Jan. 29, 1997

Positive results reported for Allervax Ragweed seasonal trial

Jan. 29, 1997

Banyu prepares selective muscarinic antagonists with reduced side effects

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...